| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 12 |
| 1 | AMOXICILLIN | 10 |
| 2 | LENALIDOMIDE | 10 |
| 3 | LEUCOVORIN CALCIUM | 10 |
| 4 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 10 |
| 5 | VALACYCLOVIR | 10 |
| 6 | VALACYCLOVIR HYDROCHLORIDE | 10 |
| 7 | AFLIBERCEPT | 6 |
| 8 | VERTEPORFIN FOR INJECTION | 4 |
| 9 | ALLOPURINOL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERTEPORFIN FOR INJECTION | 4 | 0.0027 |
| 1 | BROLUCIZUMAB | 2 | 0.0005 |
| 2 | LEUCOVORIN CALCIUM | 10 | 0.0005 |
| 3 | RANIBIZUMAB | 12 | 0.0005 |
| 4 | FLUOCINOLONE ACETONIDE | 1 | 0.0003 |
| 5 | FARICIMAB | 2 | 0.0002 |
| 6 | AFLIBERCEPT | 6 | 0.0002 |
| 7 | SOFOSBUVIR | 3 | 0.0002 |
| 8 | VALACYCLOVIR HYDROCHLORIDE | 10 | 0.0001 |
| 9 | NADOLOL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 4 | 0.0010 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 2 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 10 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 15 | 0.0001 |
| 4 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 7 | Thalidomide Analog [EPC] | 10 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 3 | 0.0000 |